RNS Number : 8969A
Burning Rock Biotech Limited
19 August 2024
 

 

 

Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares

 

Burning Rock Biotech Limited (the "Company" or "Burning Rock") announces that, on August 19, 2024, it intends to submit requests (a) to the London Stock Exchange (the "LSE"), to cancel the admission to trading on the Main Market of its American Depositary Shares representing the class A ordinary shares of the Company (the "ADSs"), and (b) to the UK Financial Conduct Authority, to cancel the listing of the ADSs on the Official List.

 

As a result of sustained low volume of trading and liquidity in the ADSs on the LSE, and taking into account the costs associated with maintaining such listing in place, the Company is seeking the delisting and cancellation of admission to trading of the ADSs from the LSE (the "Delisting"). It is anticipated that the Delisting will take effect on or about September 18, 2024.

 

Following the Delisting, the ADSs will continue to trade on the Nasdaq Global Market.

 

About Burning Rock

 

Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.

 

For more information about Burning Rock, please visit: www.brbiotech.com.

 

Contact: IR@brbiotech.com

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEASPNFLKLEEA
Burning Rock Biotech (LSE:BNR)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Burning Rock Biotech Charts.
Burning Rock Biotech (LSE:BNR)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Burning Rock Biotech Charts.